Celebrating World Diabetes Day 2024

Access to Diabetes Care

The theme of World Diabetes Day 2024 is "Diabetes and well-being". We support the millions of individuals managing diabetes and recognize the crucial and continuous research endeavours directed towards conquering the disease. Timely access to reliable information and adequate care is instrumental in ensuring swift treatment and successful disease management.

Elsevier empowers you with knowledge and valuable information to support the management of diabetes. On this World Diabetes Day 2024 we present some of the cutting-edge research published in our Endocrinology journals.

Enjoy free access to these articles until February 29, 2025.

Article collection

AACE Clinical Case Reports

• Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors Wird in neuem Tab/Fenster geöffnet

• Diabetic Ketoacidosis in a Patient With Type I Diabetes Treated With a Closed-Loop Sensor–Augmented Insulin Infusion System Wird in neuem Tab/Fenster geöffnet

Annales d'Endocrinologie

• Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Wird in neuem Tab/Fenster geöffnet

• Epidemiology and health impact of diabetes in France Wird in neuem Tab/Fenster geöffnet

Best Practice & Research Clinical Endocrinology & Metabolism

• The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I Wird in neuem Tab/Fenster geöffnet

• Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia Wird in neuem Tab/Fenster geöffnet

Bone

• Bone intrinsic material and compositional properties in postmenopausal women diagnosed with long-term Type-1 diabetes Wird in neuem Tab/Fenster geöffnet

• Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study Wird in neuem Tab/Fenster geöffnet

• Epidemiology of fractures in adults of African ancestry with diabetes mellitus: A systematic review and meta-analysis Wird in neuem Tab/Fenster geöffnet

Bone Reports

• Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study Wird in neuem Tab/Fenster geöffnet

• Type 2 diabetes alters the viscoelastic behavior and macromolecular composition of vertebra Wird in neuem Tab/Fenster geöffnet

Canadian Journal of Diabetes

• Patient-reported Benefits and Limitations of Mobile Health Technologies for Diabetes in Pregnancy: A Scoping Review Wird in neuem Tab/Fenster geöffnet

• Intervention Effect of Pender’s Model on Mental Health of Patients With Diabetes Mellitus: A Meta-analysis Wird in neuem Tab/Fenster geöffnet

• Physical Activity Participation in People With an Active Diabetic Foot Ulceration: A Scoping Review Wird in neuem Tab/Fenster geöffnet

Current Opinion in Endocrine and Metabolic Research

• Type 1 diabetes mellitus and host–bacterial interactions in the oral cavity Wird in neuem Tab/Fenster geöffnet

• Current Opinion in Endocrine and Metabolic Research: Home page Wird in neuem Tab/Fenster geöffnet

Cytokine and Growth Factor Reviews

• The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment Wird in neuem Tab/Fenster geöffnet

• Growth differentiation factor-15 and its role in diabetes and cardiovascular disease Wird in neuem Tab/Fenster geöffnet

Diabetes Epidemiology and Management

• PRODIAB: Perspectives on the use of patient-reported outcome measures among diabetic patients Wird in neuem Tab/Fenster geöffnet

• Benefits and limitations of hypo/hyperglycemic alarms associated with continuous glucose monitoring in individuals with diabetes Wird in neuem Tab/Fenster geöffnet

Diabetes & Metabolism

• Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study Wird in neuem Tab/Fenster geöffnet

• Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke Wird in neuem Tab/Fenster geöffnet

Diabetes and Metabolic Syndrome: Clinical Research & Reviews

• Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis Wird in neuem Tab/Fenster geöffnet

• Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials Wird in neuem Tab/Fenster geöffnet

Diabetes Research and Clinical Practice

• Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry Wird in neuem Tab/Fenster geöffnet

• Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions Wird in neuem Tab/Fenster geöffnet

• Obesity and diabetes Wird in neuem Tab/Fenster geöffnet

Endocrinologia, Diabetes y Nutrición (English version)

• Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study Wird in neuem Tab/Fenster geöffnet

• Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary Wird in neuem Tab/Fenster geöffnet

Endocrinología, Diabetes y Nutrición

• Gestational diabetes prevalence and outcomes in women undergoing assisted reproductive techniques (ART)Prevalencia y resultados de la diabetes gestacional en mujeres sometidas a técnicas de reproducción asistida (TRA) Wird in neuem Tab/Fenster geöffnet

• Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes Wird in neuem Tab/Fenster geöffnet

Endocrine and Metabolic Science

• Diabetic retinal neurodegeneration associated with synaptic proteins and functional defects: A systematic review Wird in neuem Tab/Fenster geöffnet

• Association of GIPR gene variant on the risk of type 2 diabetes mellitus: A case-control study Wird in neuem Tab/Fenster geöffnet

• Risk factors related to diabetic retinopathy in Vietnamese patients with type 2 diabetes mellitus Wird in neuem Tab/Fenster geöffnet

Endocrine Practice

• American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update Wird in neuem Tab/Fenster geöffnet

• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update Wird in neuem Tab/Fenster geöffnet

Growth Hormone & IGF Research

• Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Wird in neuem Tab/Fenster geöffnet

• A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury Wird in neuem Tab/Fenster geöffnet

Journal of Clinical and Translational Endocrinology

• Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease Wird in neuem Tab/Fenster geöffnet

Journal of Clinical and Translational Endocrinology: Case Reports

• Hypertriglyceridemia in gestational diabetes: Case report and review of the literature Wird in neuem Tab/Fenster geöffnet

Journal of Clinical Densitometry

• Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients Wird in neuem Tab/Fenster geöffnet

• Bone Metabolism Discrepancy in Type 2 Diabetes Mellitus Patients With and Without Non-Alcoholic Fatty Liver Disease Wird in neuem Tab/Fenster geöffnet

Journal of Diabetes and its complications

• Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist Wird in neuem Tab/Fenster geöffnet

• Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review Wird in neuem Tab/Fenster geöffnet

• Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials Wird in neuem Tab/Fenster geöffnet

Metabolism

• Metformin: Is it a drug for all reasons and diseases? Wird in neuem Tab/Fenster geöffnet

• Insulin: The master regulator of glucose metabolism Wird in neuem Tab/Fenster geöffnet

Metabolism Open

• The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review Wird in neuem Tab/Fenster geöffnet

Molecular and Cellular Endocrinology

• Decoding the role of microRNA dysregulation in the interplay of pancreatic cancer and type 2 diabetes Wird in neuem Tab/Fenster geöffnet

• Insulin signaling and mitochondrial phenotype of skeletal muscle are programmed in utero by maternal diabetes Wird in neuem Tab/Fenster geöffnet

• Impact of different hormones on the regulation of nitric oxide in diabetes Wird in neuem Tab/Fenster geöffnet

Obesity Pillars

• Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 Wird in neuem Tab/Fenster geöffnet

• Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 Wird in neuem Tab/Fenster geöffnet

Obesity Research and Clinical Practice

• Associations between obesity parameters and hyperuricemia by sex, age, and diabetes mellitus: A nationwide study in Korea Wird in neuem Tab/Fenster geöffnet

• Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence Wird in neuem Tab/Fenster geöffnet

Peptides

• An update on peptide-based therapies for type 2 diabetes and obesity Wird in neuem Tab/Fenster geöffnet

• Recent advances in peptide-based therapies for obesity and type 2 diabetes Wird in neuem Tab/Fenster geöffnet

• Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity Wird in neuem Tab/Fenster geöffnet

Primary Care Diabetes

• Socio-personal factors affecting adherence to treatment in patients with type 2 diabetes: A systematic review and meta-analysis Wird in neuem Tab/Fenster geöffnet

• Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis Wird in neuem Tab/Fenster geöffnet

• Diabetes mellitus-related musculoskeletal disorders: Unveiling the cluster of diseases Wird in neuem Tab/Fenster geöffnet

Prostaglandins, Leukotrienes and Essential Fatty Acids

• Placental F4-Neuroprostanes and F2-Isoprostanes are altered in gestational diabetes mellitus and maternal obesity Wird in neuem Tab/Fenster geöffnet

• Omega-3 index and type 2 diabetes: Systematic review and meta-analysis Wird in neuem Tab/Fenster geöffnet

Steroids

• Vitamin D status and its association with inflammatory markers among Kurdish type 2 diabetic patients with painful diabetic peripheral neuropathy Wird in neuem Tab/Fenster geöffnet

• Anti-diabetic effects of fungal Ergosta-4, 6, 8(14), 22-tetraen-3-one from Pholiota adiposa Wird in neuem Tab/Fenster geöffnet

The Journal of Steroid Biochemistry and Molecular Biology

• Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes Wird in neuem Tab/Fenster geöffnet

• The effects of 1,25(OH)2D3 treatment on metabolic reprogramming and maturation in bone marrow-derived dendritic cells from control and diabetic mice Wird in neuem Tab/Fenster geöffnet